Medifast (NYSE:MED) Releases Earnings Results, Beats Estimates By $0.26 EPS

Medifast (NYSE:MED) announced its quarterly earnings data on Tuesday. The specialty retailer reported $0.10 earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.26, Zacks reports. Medifast had a return on equity of 15.98% and a net margin of 1.09%. Medifast updated its Q1 2025 guidance to -0.500-0.000 EPS.

Medifast Stock Down 1.0 %

Shares of NYSE:MED opened at $16.05 on Wednesday. Medifast has a 52-week low of $14.76 and a 52-week high of $49.90. The company has a market capitalization of $175.59 million, a PE ratio of 24.32 and a beta of 1.14. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.55 and a current ratio of 3.11. The company has a fifty day moving average of $16.61 and a 200-day moving average of $18.05.

Wall Street Analysts Forecast Growth

Separately, DA Davidson raised shares of Medifast from an “underperform” rating to a “neutral” rating and increased their target price for the stock from $16.50 to $17.00 in a report on Tuesday, November 5th.

About Medifast

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.